' Акцијски курс '

Datum	Shanghai Fosun Pharmaceutical Group Co Promet	Shanghai Fosun Pharmaceutical Group Co EBIT	Shanghai Fosun Pharmaceutical Group Co Profit
2026e	53,25 milijardi undefined	2,71 milijardi undefined	3,67 milijardi undefined
2025e	49,15 milijardi undefined	2,75 milijardi undefined	3,24 milijardi undefined
2024e	45,24 milijardi undefined	2,41 milijardi undefined	2,78 milijardi undefined
2023	41,40 milijardi undefined	1,29 milijardi undefined	2,39 milijardi undefined
2022	43,95 milijardi undefined	3,50 milijardi undefined	3,73 milijardi undefined
2021	39,01 milijardi undefined	2,55 milijardi undefined	4,74 milijardi undefined
2020	30,31 milijardi undefined	2,64 milijardi undefined	3,66 milijardi undefined
2019	28,59 milijardi undefined	2,49 milijardi undefined	3,32 milijardi undefined
2018	24,92 milijardi undefined	2,29 milijardi undefined	2,71 milijardi undefined
2017	18,53 milijardi undefined	2,24 milijardi undefined	3,12 milijardi undefined
2016	14,63 milijardi undefined	1,64 milijardi undefined	2,81 milijardi undefined
2015	12,61 milijardi undefined	1,36 milijardi undefined	2,46 milijardi undefined
2014	12,03 milijardi undefined	1,11 milijardi undefined	2,11 milijardi undefined
2013	10,00 milijardi undefined	1,03 milijardi undefined	1,58 milijardi undefined
2012	7,34 milijardi undefined	553,00 mil. undefined	1,56 milijardi undefined
2011	6,49 milijardi undefined	324,00 mil. undefined	1,17 milijardi undefined
2010	4,56 milijardi undefined	163,00 mil. undefined	864,00 mil. undefined
2009	3,87 milijardi undefined	157,00 mil. undefined	2,50 milijardi undefined
2008	3,77 milijardi undefined	118,00 mil. undefined	691,00 mil. undefined
2007	3,69 milijardi undefined	164,00 mil. undefined	626,00 mil. undefined
2006	4,08 milijardi undefined	92,00 mil. undefined	258,00 mil. undefined
2005	2,99 milijardi undefined	143,00 mil. undefined	159,00 mil. undefined
2004	2,43 milijardi undefined	153,00 mil. undefined	215,00 mil. undefined

	Promet	EBIT	Profit
2004	2,43 milijardi CNY	153,00 mil. CNY	215,00 mil. CNY
2005	2,99 milijardi CNY	143,00 mil. CNY	159,00 mil. CNY
2006	4,08 milijardi CNY	92,00 mil. CNY	258,00 mil. CNY
2007	3,69 milijardi CNY	164,00 mil. CNY	626,00 mil. CNY
2008	3,77 milijardi CNY	118,00 mil. CNY	691,00 mil. CNY
2009	3,87 milijardi CNY	157,00 mil. CNY	2,50 milijardi CNY
2010	4,56 milijardi CNY	163,00 mil. CNY	864,00 mil. CNY
2011	6,49 milijardi CNY	324,00 mil. CNY	1,17 milijardi CNY
2012	7,34 milijardi CNY	553,00 mil. CNY	1,56 milijardi CNY
2013	10,00 milijardi CNY	1,03 milijardi CNY	1,58 milijardi CNY
2014	12,03 milijardi CNY	1,11 milijardi CNY	2,11 milijardi CNY
2015	12,61 milijardi CNY	1,36 milijardi CNY	2,46 milijardi CNY
2016	14,63 milijardi CNY	1,64 milijardi CNY	2,81 milijardi CNY
2017	18,53 milijardi CNY	2,24 milijardi CNY	3,12 milijardi CNY
2018	24,92 milijardi CNY	2,29 milijardi CNY	2,71 milijardi CNY
2019	28,59 milijardi CNY	2,49 milijardi CNY	3,32 milijardi CNY
2020	30,31 milijardi CNY	2,64 milijardi CNY	3,66 milijardi CNY
2021	39,01 milijardi CNY	2,55 milijardi CNY	4,74 milijardi CNY
2022	43,95 milijardi CNY	3,50 milijardi CNY	3,73 milijardi CNY
2023	41,40 milijardi CNY	1,29 milijardi CNY	2,39 milijardi CNY
2024e	45,24 milijardi CNY	2,41 milijardi CNY	2,78 milijardi CNY
2025e	49,15 milijardi CNY	2,75 milijardi CNY	3,24 milijardi CNY
2026e	53,25 milijardi CNY	2,71 milijardi CNY	3,67 milijardi CNY

Shanghai Fosun Pharmaceutical Group Co Bruto marža	Shanghai Fosun Pharmaceutical Group Co Profitna marža	Shanghai Fosun Pharmaceutical Group Co EBIT marža	Shanghai Fosun Pharmaceutical Group Co Profitna marža
2026e	47,54 %	5,09 %	6,90 %
2025e	47,54 %	5,59 %	6,58 %
2024e	47,54 %	5,33 %	6,15 %
2023	47,54 %	3,11 %	5,76 %
2022	47,09 %	7,97 %	8,49 %
2021	47,97 %	6,54 %	12,14 %
2020	55,47 %	8,72 %	12,09 %
2019	59,57 %	8,71 %	11,62 %
2018	58,34 %	9,17 %	10,87 %
2017	58,84 %	12,06 %	16,86 %
2016	53,81 %	11,23 %	19,18 %
2015	49,78 %	10,81 %	19,51 %
2014	43,87 %	9,19 %	17,57 %
2013	44,22 %	10,30 %	15,84 %
2012	43,62 %	7,53 %	21,31 %
2011	37,63 %	5,00 %	17,98 %
2010	33,90 %	3,58 %	18,97 %
2009	32,02 %	4,05 %	64,51 %
2008	27,67 %	3,13 %	18,31 %
2007	26,59 %	4,44 %	16,95 %
2006	21,34 %	2,25 %	6,32 %
2005	29,98 %	4,78 %	5,32 %
2004	31,22 %	6,31 %	8,87 %

	Bruto marža	EBIT marža	Profitna marža
2004	31,22 %	6,31 %	8,87 %
2005	29,98 %	4,78 %	5,32 %
2006	21,34 %	2,25 %	6,32 %
2007	26,59 %	4,44 %	16,95 %
2008	27,67 %	3,13 %	18,31 %
2009	32,02 %	4,05 %	64,51 %
2010	33,90 %	3,58 %	18,97 %
2011	37,63 %	5,00 %	17,98 %
2012	43,62 %	7,53 %	21,31 %
2013	44,22 %	10,30 %	15,84 %
2014	43,87 %	9,19 %	17,57 %
2015	49,78 %	10,81 %	19,51 %
2016	53,81 %	11,23 %	19,18 %
2017	58,84 %	12,06 %	16,86 %
2018	58,34 %	9,17 %	10,87 %
2019	59,57 %	8,71 %	11,62 %
2020	55,47 %	8,72 %	12,09 %
2021	47,97 %	6,54 %	12,14 %
2022	47,09 %	7,97 %	8,49 %
2023	47,54 %	3,11 %	5,76 %
2024e	47,54 %	5,33 %	6,15 %
2025e	47,54 %	5,59 %	6,58 %
2026e	47,54 %	5,09 %	6,90 %

Datum	Shanghai Fosun Pharmaceutical Group Co Prihod po akciji	Shanghai Fosun Pharmaceutical Group Co EBIT po akciji	Shanghai Fosun Pharmaceutical Group Co Dobit po akciji
2026e	25,16 undefined	0 undefined	1,73 undefined
2025e	23,22 undefined	0 undefined	1,53 undefined
2024e	21,37 undefined	0 undefined	1,31 undefined
2023	15,51 undefined	0,48 undefined	0,89 undefined
2022	16,86 undefined	1,34 undefined	1,43 undefined
2021	15,22 undefined	1,00 undefined	1,85 undefined
2020	11,82 undefined	1,03 undefined	1,43 undefined
2019	11,15 undefined	0,97 undefined	1,30 undefined
2018	9,88 undefined	0,91 undefined	1,07 undefined
2017	7,53 undefined	0,91 undefined	1,27 undefined
2016	6,28 undefined	0,71 undefined	1,20 undefined
2015	5,43 undefined	0,59 undefined	1,06 undefined
2014	5,24 undefined	0,48 undefined	0,92 undefined
2013	4,46 undefined	0,46 undefined	0,71 undefined
2012	3,28 undefined	0,25 undefined	0,70 undefined
2011	3,41 undefined	0,17 undefined	0,61 undefined
2010	2,42 undefined	0,09 undefined	0,46 undefined
2009	2,09 undefined	0,08 undefined	1,35 undefined
2008	2,03 undefined	0,06 undefined	0,37 undefined
2007	1,99 undefined	0,09 undefined	0,34 undefined
2006	2,20 undefined	0,05 undefined	0,14 undefined
2005	1,84 undefined	0,09 undefined	0,10 undefined
2004	1,50 undefined	0,09 undefined	0,13 undefined

	Prihod po akciji	EBIT po akciji	Dobit po akciji
2004	1,50 CNY	0,09 CNY	0,13 CNY
2005	1,84 CNY	0,09 CNY	0,10 CNY
2006	2,20 CNY	0,05 CNY	0,14 CNY
2007	1,99 CNY	0,09 CNY	0,34 CNY
2008	2,03 CNY	0,06 CNY	0,37 CNY
2009	2,09 CNY	0,08 CNY	1,35 CNY
2010	2,42 CNY	0,09 CNY	0,46 CNY
2011	3,41 CNY	0,17 CNY	0,61 CNY
2012	3,28 CNY	0,25 CNY	0,70 CNY
2013	4,46 CNY	0,46 CNY	0,71 CNY
2014	5,24 CNY	0,48 CNY	0,92 CNY
2015	5,43 CNY	0,59 CNY	1,06 CNY
2016	6,28 CNY	0,71 CNY	1,20 CNY
2017	7,53 CNY	0,91 CNY	1,27 CNY
2018	9,88 CNY	0,91 CNY	1,07 CNY
2019	11,15 CNY	0,97 CNY	1,30 CNY
2020	11,82 CNY	1,03 CNY	1,43 CNY
2021	15,22 CNY	1,00 CNY	1,85 CNY
2022	16,86 CNY	1,34 CNY	1,43 CNY
2023	15,51 CNY	0,48 CNY	0,89 CNY
2024e	21,37 CNY	0 CNY	1,31 CNY
2025e	23,22 CNY	0 CNY	1,53 CNY
2026e	25,16 CNY	0 CNY	1,73 CNY

	Broj akcija
2004	1,61 milijardi Aktien
2005	1,62 milijardi Aktien
2006	1,86 milijardi Aktien
2007	1,86 milijardi Aktien
2008	1,86 milijardi Aktien
2009	1,86 milijardi Aktien
2010	1,89 milijardi Aktien
2011	1,90 milijardi Aktien
2012	2,24 milijardi Aktien
2013	2,24 milijardi Aktien
2014	2,30 milijardi Aktien
2015	2,32 milijardi Aktien
2016	2,33 milijardi Aktien
2017	2,46 milijardi Aktien
2018	2,52 milijardi Aktien
2019	2,56 milijardi Aktien
2020	2,56 milijardi Aktien
2021	2,56 milijardi Aktien
2022	2,61 milijardi Aktien
2023	2,67 milijardi Aktien
2024e	2,67 milijardi Aktien
2025e	2,67 milijardi Aktien
2026e	2,67 milijardi Aktien

Datum	Shanghai Fosun Pharmaceutical Group Co Dividenda
2026e	0,44 undefined
2025e	0,44 undefined
2024e	0,44 undefined
2023	0,42 undefined
2022	0,56 undefined
2021	0,43 undefined
2020	0,39 undefined
2019	0,32 undefined
2018	0,38 undefined
2017	0,35 undefined
2016	0,32 undefined
2015	0,28 undefined
2014	0,27 undefined
2013	0,21 undefined
2012	0,10 undefined
2011	0,10 undefined
2010	0,07 undefined
2009	0,07 undefined
2008	0,07 undefined
2007	0,05 undefined
2006	0,17 undefined
2005	0,08 undefined
2004	0,10 undefined

	Dividenda	Dividenda (procena)
2004	0,10 CNY	0 CNY
2005	0,08 CNY	0 CNY
2006	0,17 CNY	0 CNY
2007	0,05 CNY	0 CNY
2008	0,07 CNY	0 CNY
2009	0,07 CNY	0 CNY
2010	0,07 CNY	0 CNY
2011	0,10 CNY	0 CNY
2012	0,10 CNY	0 CNY
2013	0,21 CNY	0 CNY
2014	0,27 CNY	0 CNY
2015	0,28 CNY	0 CNY
2016	0,32 CNY	0 CNY
2017	0,35 CNY	0 CNY
2018	0,38 CNY	0 CNY
2019	0,32 CNY	0 CNY
2020	0,39 CNY	0 CNY
2021	0,43 CNY	0 CNY
2022	0,56 CNY	0 CNY
2023	0,42 CNY	0 CNY
2024e	0 CNY	0,44 CNY
2025e	0 CNY	0,44 CNY
2026e	0 CNY	0,44 CNY

Datum	Shanghai Fosun Pharmaceutical Group Co Stopa distribucije
2026e	31,31 %
2025e	33,27 %
2024e	30,77 %
2023	29,89 %
2022	39,14 %
2021	23,27 %
2020	27,27 %
2019	24,62 %
2018	35,51 %
2017	27,56 %
2016	26,67 %
2015	26,42 %
2014	29,35 %
2013	29,58 %
2012	14,29 %
2011	16,39 %
2010	14,49 %
2009	4,94 %
2008	18,02 %
2007	15,08 %
2006	124,54 %
2005	76,92 %
2004	78,90 %

	Stopa distribucije
2004	78,90 %
2005	76,92 %
2006	124,54 %
2007	15,08 %
2008	18,02 %
2009	4,94 %
2010	14,49 %
2011	16,39 %
2012	14,29 %
2013	29,58 %
2014	29,35 %
2015	26,42 %
2016	26,67 %
2017	27,56 %
2018	35,51 %
2019	24,62 %
2020	27,27 %
2021	23,27 %
2022	39,14 %
2023	29,89 %
2024e	30,77 %
2025e	33,27 %
2026e	31,31 %

Datum	Procena EPSa	EPS-Actual	Kvartal izveštaja
31. 3. 2024.	0,35	0,23 (-34,00 %)	2024 Q1
31. 12. 2023.	0,41	0,04 (-90,22 %)	2023 Q4
30. 9. 2023.	0,39	0,19 (-52,79 %)	2023 Q3
30. 6. 2023.	0,33	0,30 (-8,62 %)	2023 Q2
31. 3. 2023.	0,38	0,37 (-3,60 %)	2023 Q1
31. 12. 2022.	0,38	0,48 (26,72 %)	2022 Q4
30. 9. 2022.	0,41	0,34 (-16,89 %)	2022 Q3
30. 6. 2022.	0,43	0,42 (-2,17 %)	2022 Q2
31. 3. 2022.	0,37	0,18 (-51,83 %)	2022 Q1
31. 12. 2021.	0,34	0,46 (33,95 %)	2021 Q4
30. 9. 2021.	0,47	0,42 (-11,52 %)	2021 Q3
30. 6. 2021.	0,96	0,33 (-65,61 %)	2021 Q2
31. 3. 2021.	0,34	0,33 (-3,90 %)	2021 Q1
31. 12. 2020.	0,44	0,46 (3,51 %)	2020 Q4
30. 9. 2020.	0,31	0,30 (-4,18 %)	2020 Q3
30. 6. 2020.	0,36	0,44 (22,70 %)	2020 Q2
31. 3. 2020.	0,22	0,23 (6,73 %)	2020 Q1
31. 12. 2019.	0,63	0,49 (-22,58 %)	2019 Q4
30. 9. 2019.	0,29	0,22 (-23,58 %)	2019 Q3
30. 6. 2019.	0,35	0,31 (-11,28 %)	2019 Q2
31. 3. 2019.	0,33	0,28 (-14,71 %)	2019 Q1
31. 12. 2018.	0,27	0,24 (-11,99 %)	2018 Q4
30. 9. 2018.	0,35	0,20 (-43,42 %)	2018 Q3
30. 6. 2018.	0,40	0,35 (-13,37 %)	2018 Q2
31. 3. 2018.	0,33	0,28 (-15,99 %)	2018 Q1
31. 12. 2017.	0,32	0,28 (-13,06 %)	2017 Q4
30. 9. 2017.	0,31	0,29 (-7,53 %)	2017 Q3
30. 6. 2017.	0,41	0,39 (-4,53 %)	2017 Q2
31. 3. 2017.	0,31	0,31 (0,62 %)	2017 Q1
31. 12. 2016.	0,29	0,26 (-11,23 %)	2016 Q4
30. 9. 2016.	0,31	0,29 (-5,35 %)	2016 Q3
30. 6. 2016.	0,35	0,37 (5,87 %)	2016 Q2
31. 3. 2016.	0,28	0,27 (-4,53 %)	2016 Q1
31. 12. 2015.	0,28	0,24 (-13,61 %)	2015 Q4
30. 9. 2015.	0,30	0,25 (-17,49 %)	2015 Q3
30. 6. 2015.	0,28	0,33 (16,69 %)	2015 Q2
31. 3. 2015.	0,24	0,23 (-5,12 %)	2015 Q1
31. 12. 2014.	0,28	0,23 (-19,10 %)	2014 Q4
30. 9. 2014.	0,29	0,24 (-16,03 %)	2014 Q3
30. 6. 2014.	0,34	0,25 (-25,04 %)	2014 Q2
31. 12. 2011.	0,09	0,05 (-44,88 %)	2011 Q4

%	Ime	Акције	Promena	Datum
41,87 %	Shanghai Fosun High Technology (Group) Co., Ltd.	886.315.955	0	31. 12. 2023.
1,14 %	China Merchants Fund Management Co. Ltd.	24.106.618	-818.400	31. 12. 2023.
0,87 %	E Fund Management Co. Ltd.	18.389.093	-571.853	31. 12. 2023.
0,54 %	Yinhua Fund Management Co., Ltd.	11.537.035	1.020.740	31. 12. 2023.
0,44 %	Huatai-PineBridge Fund Management Co., Ltd.	9.369.625	1.212.600	31. 12. 2023.
0,41 %	China Universal Asset Management Co., Ltd.	8.724.081	-835.598	31. 12. 2023.
0,37 %	Yunnan Qijia Investment Co., Ltd.	7.896.749	0	31. 12. 2023.
0,37 %	Tianhong Asset Management Co., Ltd.	7.866.489	0	31. 12. 2023.
0,35 %	GF Fund Management Co., Ltd.	7.371.877	-1.100	31. 12. 2023.
0,29 %	CITIC Securities Co., Ltd. (Asset Management)	6.162.837	6.162.837	31. 12. 2023.
0,20 %	The Vanguard Group, Inc.	4.197.813	-281.800	31. 3. 2024.
0,17 %	BlackRock Institutional Trust Company, N.A.	3.573.033	-39.000	31. 3. 2024.
0,13 %	Harvest Fund Management Co., Ltd.	2.827.232	0	29. 2. 2024.
0,13 %	HuaAn Fund Management Co., Ltd.	2.694.281	22.900	31. 12. 2023.
0,12 %	BlackRock Advisors (UK) Limited	2.468.160	74.000	31. 3. 2024.
0,11 %	Penghua Fund Management Co., Ltd.	2.257.391	2.026.300	30. 6. 2023.
0,08 %	Hwabao WP Fund Management Co., Ltd.	1.693.700	1.639.900	30. 6. 2023.
0,07 %	Fullgoal Fund Management Co., Ltd.	1.501.846	15.400	31. 12. 2023.
0,07 %	Norges Bank Investment Management (NBIM)	1.380.948	-2.427.756	31. 12. 2023.
0,07 %	Wu (Yifang)	1.380.100	0	31. 12. 2023.
0,05 %	Guotai Asset Management Co., Ltd.	1.146.860	82.100	31. 12. 2023.
0,05 %	Harvest Global Investments Limited	1.033.814	0	31. 3. 2024.
0,05 %	Galaxy Asset Management Co., Ltd.	1.025.484	-1.200	31. 12. 2023.
0,05 %	China Southern Asset Management Co. Ltd.	1.021.224	-5.800	31. 12. 2023.
0,04 %	China Asset Management (Hong Kong) Limited	851.340	65.600	31. 3. 2024.
0,04 %	Fortune & Royal Asset Management Company Limited	814.200	165.000	30. 6. 2023.
0,04 %	ICBC Credit Suisse Asset Management Co. Ltd.	770.131	252.500	30. 6. 2023.
0,03 %	DWS Investments UK Limited	728.976	-549	31. 3. 2024.
0,03 %	Amundi Asset Management, SAS	712.160	181.060	31. 3. 2024.
0,03 %	Essence Fund Management Co., Ltd.	580.002	1.500	31. 12. 2023.
0,03 %	SWS MU Fund Management Co., Ltd.	549.552	-9.004	31. 12. 2023.
0,02 %	Handelsbanken Kapitalförvaltning AB	498.700	0	31. 3. 2024.
0,02 %	CITIC Prudential Fund Management Co., Ltd.	497.835	-1.400	31. 12. 2023.
0,02 %	Wang (Ke Xin)	467.700	0	31. 12. 2023.
0,02 %	Yao (Fang)	458.300	0	31. 12. 2023.
0,02 %	CCB Principal Asset Management Co., Ltd.	430.646	-3.400	31. 12. 2023.
0,02 %	Mellon Investments Corporation	427.577	-77.300	31. 3. 2024.
0,02 %	State Street Global Advisors (US)	426.982	-12.500	31. 3. 2024.
0,02 %	Guan (Xiao Hui)	418.100	0	31. 12. 2023.
0,02 %	BlackRock (Singapore) Limited	369.335	79.900	31. 3. 2024.
0,02 %	Taikang Asset Management Co., Ltd.	338.405	-3.800	30. 6. 2023.
0,02 %	Geode Capital Management, L.L.C.	334.800	5.700	29. 2. 2024.
0,01 %	Aviva Investors Global Services Limited	313.721	107.544	29. 2. 2024.
0,01 %	Bosera Asset Management Co., Ltd.	286.200	98.357	31. 12. 2023.
0,01 %	Tibet Eastmoney Fund Management Co., Ltd.	279.700	-26.600	31. 12. 2023.
0,01 %	JPMorgan Asset Management (China) Company Limited.	273.000	23.500	30. 6. 2023.
0,01 %	California State Teachers Retirement System	262.400	84.800	30. 6. 2023.
0,01 %	State Street Global Advisors (UK) Ltd.	261.367	1	31. 3. 2024.
0,01 %	UBS Asset Management (UK) Ltd.	248.800	300	31. 3. 2024.
0,01 %	Credit Suisse Funds AG	231.712	-2.100	31. 3. 2024.
0,01 %	Wen (Deyong)	227.100	0	31. 12. 2023.
0,01 %	China Life AMP Asset Management Co., Ltd	207.600	17.500	31. 12. 2023.
0,01 %	Krane Funds Advisors, LLC	186.929	4.600	31. 3. 2024.
0,01 %	Nuveen LLC	183.988	0	31. 3. 2024.
0,01 %	Northern Trust Global Investments Limited	178.000	0	29. 2. 2024.
0,01 %	BlackRock Investment Management (UK) Ltd.	162.500	0	29. 2. 2024.
0,01 %	Charles Schwab Investment Management, Inc.	161.200	0	31. 3. 2024.
0,01 %	Amundi Japan Ltd.	160.600	3.300	31. 3. 2024.
0,01 %	DWS Investment GmbH	155.075	-3.600	31. 3. 2024.
0,01 %	Chen (Yu Qing)	154.000	0	31. 12. 2023.
0,01 %	Florida State Board of Administration	143.600	93.000	30. 9. 2022.
0,01 %	Nuode Asset Management Company Limited	142.500	23.900	30. 6. 2023.
0,01 %	Changsheng Fund Management Co., Ltd.	141.864	-4.500	31. 12. 2023.
0,01 %	CPIC Fund Management Co., Ltd.	138.654	-1.000	31. 12. 2023.
0,01 %	Fubon Asset Management Company Ltd.	134.545	-12.300	29. 2. 2024.
0,01 %	HSBC Global Asset Management (UK) Limited	130.882	200	29. 2. 2024.
0,01 %	First Seafront Fund Management Co., Ltd.	125.951	0	31. 12. 2023.
0,01 %	Huashang Fund Management Co., Ltd.	125.900	-658.300	30. 6. 2023.
0,01 %	Hony Horizon Fund Management Co., Ltd.	121.000	2.700	30. 6. 2023.
0,01 %	LBP AM	115.160	36.105	29. 2. 2024.
0,01 %	UBS Asset Management (Switzerland)	114.200	0	29. 2. 2024.
0,01 %	Chen (Qi Yu)	114.075	0	31. 12. 2023.
0,01 %	Feng (Rongli)	113.500	0	31. 12. 2023.
0,01 %	Wang (Donghua)	113.500	0	31. 12. 2023.
0,01 %	Li (Jing)	113.500	0	31. 12. 2023.
0,01 %	Caitong Fund Management Co., Ltd.	110.700	28.300	30. 6. 2023.
0,01 %	PGGM Vermogensbeheer B.V.	110.010	-357	31. 7. 2023.
0,00 %	Mercer Global Investments Management Ltd	103.200	0	31. 3. 2024.
0,00 %	Pictet Asset Management Ltd.	99.600	-5.400	31. 12. 2023.
0,00 %	Cardano Asset Management NV	97.176	97.176	29. 2. 2024.
0,00 %	BOCI-Prudential Asset Management Ltd.	89.500	900	29. 2. 2024.
0,00 %	ABC-CA Fund Management Co., Ltd.	84.442	-400	31. 12. 2023.
0,00 %	Franklin Templeton Sealand Fund Management Co., Ltd.	83.200	83.172	30. 6. 2023.
0,00 %	Dong (Xiao Xian)	81.800	0	31. 12. 2023.
0,00 %	Mei (Jing Ping)	80.300	0	31. 12. 2023.
0,00 %	Mirae Asset Global Investments Co., Ltd.	78.704	334	31. 1. 2024.
0,00 %	Wanjia Asset Management Co., Ltd.	77.549	-2.500	31. 12. 2023.
0,00 %	Founder Fubon Fund Management Co., Ltd.	70.900	-354.100	30. 6. 2023.
0,00 %	Legal & General Investment Management Ltd.	70.900	-14.000	29. 2. 2024.
0,00 %	CICC Fund Management Co Ltd.	70.300	5.400	31. 12. 2023.
0,00 %	Xu (Aihua)	70.200	0	31. 12. 2023.
0,00 %	Li (Dongjiu)	66.800	46.800	31. 12. 2023.
0,00 %	Liu (Yi)	66.800	0	31. 12. 2023.
0,00 %	Bao (Qingui)	66.800	0	31. 12. 2023.
0,00 %	Minsheng Royal Fund Management Company Ltd.	65.943	-6.700	30. 6. 2023.
0,00 %	PICC Asset Management Company Limited	64.500	24.200	30. 6. 2023.
0,00 %	Manulife Fund Management Co., Ltd.	57.700	36.200	30. 6. 2023.
0,00 %	Zhu (Yue)	56.800	0	31. 12. 2023.
0,00 %	Hang Seng Investment Management Ltd.	53.975	-622	31. 3. 2024.
0,00 %	Nykredit Bank AS	49.901	36.501	29. 2. 2024.

What values and corporate philosophy does Shanghai Fosun Pharmaceutical Group Co represent?

Shanghai Fosun Pharmaceutical Group Co Ltd represents a set of core values and a strong corporate philosophy. With a focus on innovation, integrity, and social responsibility, the company strives to deliver high-quality pharmaceutical products and healthcare services. Shanghai Fosun Pharmaceutical Group Co Ltd believes in fostering sustainable development and prioritizes the well-being of patients and the community. The company's dedication to excellence, patient-centric approach, and continuous research and development efforts make it a prominent player in the pharmaceutical industry. Shanghai Fosun Pharmaceutical Group Co Ltd exemplifies a commitment to quality, ethical practices, and making a positive impact on society.

In which countries and regions is Shanghai Fosun Pharmaceutical Group Co primarily present?

The Shanghai Fosun Pharmaceutical Group Co Ltd primarily operates and has a significant presence in multiple countries and regions. The company is mainly active in China, where its headquarters is located. It also has a strong presence in various other regions and countries, including the United States, Europe, India, and Africa. Shanghai Fosun Pharmaceutical Group Co Ltd focuses on expanding its global footprint through strategic partnerships, collaborations, and acquisitions. With its diversified portfolio and global operations, the company continues to deliver innovative healthcare solutions and contribute to the well-being of people worldwide.

What significant milestones has the company Shanghai Fosun Pharmaceutical Group Co achieved?

Shanghai Fosun Pharmaceutical Group Co Ltd has achieved several significant milestones in its history. The company has demonstrated consistent growth and expansion, becoming one of the leading pharmaceutical companies in China. It has successfully developed and marketed various innovative drugs, contributing to improved healthcare outcomes for patients. Shanghai Fosun Pharmaceutical Group Co Ltd has also made strategic acquisitions and formed partnerships to strengthen its market presence both domestically and internationally. Additionally, the company has received recognition for its commitment to research and development, as well as its contributions to healthcare philanthropy. These achievements make Shanghai Fosun Pharmaceutical Group Co Ltd a formidable player in the pharmaceutical industry.

What is the history and background of the company Shanghai Fosun Pharmaceutical Group Co?

Shanghai Fosun Pharmaceutical Group Co Ltd, commonly known as Fosun Pharma, is a leading Chinese pharmaceutical company. Established in 1994, the company has a rich history and a strong background in the healthcare industry. Fosun Pharma focuses on research, development, manufacturing, and distribution of a wide range of pharmaceutical products, including prescription drugs, over-the-counter medicines, and medical devices. Over the years, Fosun Pharma has expanded its presence globally and has become one of the largest comprehensive healthcare groups in China. With a commitment to innovation and high-quality products, Shanghai Fosun Pharmaceutical Group Co Ltd continues to make significant contributions to the advancement of healthcare worldwide.

Who are the main competitors of Shanghai Fosun Pharmaceutical Group Co in the market?

The main competitors of Shanghai Fosun Pharmaceutical Group Co Ltd in the market include multinational pharmaceutical companies such as Johnson & Johnson, Pfizer, Novartis, and GlaxoSmithKline. These competitors are well-established players in the global pharmaceutical industry and offer a wide range of products and services similar to Shanghai Fosun Pharmaceutical Group. As Shanghai Fosun Pharmaceutical Group aims to expand globally and capture a larger market share, it faces strong competition from these industry giants. However, Shanghai Fosun Pharmaceutical Group has its unique strengths, product portfolio, and innovative strategies to differentiate itself and gain a competitive advantage in the market.

In which industries is Shanghai Fosun Pharmaceutical Group Co primarily active?

Shanghai Fosun Pharmaceutical Group Co Ltd is primarily active in the pharmaceutical industry.

What is the business model of Shanghai Fosun Pharmaceutical Group Co?

The business model of Shanghai Fosun Pharmaceutical Group Co Ltd focuses on various aspects of the pharmaceutical industry. As a leading healthcare company, it engages in research and development, manufacturing, sales, and distribution of pharmaceutical products. Shanghai Fosun Pharmaceutical Group Co Ltd is committed to promoting innovation and improving the accessibility of healthcare products and services. It operates through segments such as pharmaceutical manufacturing, research and development, distribution and retail, and medical services. By leveraging its strong industry expertise and strategic partnerships, Shanghai Fosun Pharmaceutical Group Co Ltd aims to contribute to the advancement of healthcare and provide high-quality medical solutions to customers worldwide.

Koji P/E odnos ima Shanghai Fosun Pharmaceutical Group Co 2024?

P/E odnos Shanghai Fosun Pharmaceutical Group Co iznosi 22,12.

Koji je KUV za Shanghai Fosun Pharmaceutical Group Co 2024?

KUV kompanije Shanghai Fosun Pharmaceutical Group Co iznosi 1,36.

Koji AlleAktien kvalitetni skor ima Shanghai Fosun Pharmaceutical Group Co?

AlleAktien kvalitativni skor za Shanghai Fosun Pharmaceutical Group Co je 4/10.

Koliki je prihod od Shanghai Fosun Pharmaceutical Group Co 2024?

očekivana Shanghai Fosun Pharmaceutical Group Co promet je 45,24 milijardi CNY.

Koliki je profit kompanije Shanghai Fosun Pharmaceutical Group Co 2024?

Dobit očekivana Shanghai Fosun Pharmaceutical Group Co je 2,78 milijardi CNY.

Шта ради Shanghai Fosun Pharmaceutical Group Co?

The Shanghai Fosun Pharmaceutical Group Co Ltd is a leading company in the development, manufacturing, and marketing of pharmaceutical products and medical services. The business model is based on a diversified portfolio of business activities focused on various segments of the healthcare industry. The company's first division is the manufacturing of pharmaceutical products. Shanghai Fosun Pharma produces a wide range of medical products, including drugs, diagnostics, and medical devices. The company specializes in innovative drug manufacturing to offer high-quality medical solutions to its customers, with a strong emphasis on product quality. Another important division is research and development. Shanghai Fosun Pharma invests significantly in researching and developing new drugs and therapies. The company collaborates closely with international partners to develop innovative technologies and products that meet market needs. In addition to these activities, the company also operates hospitals, healthcare centers, and care facilities. Shanghai Fosun Pharma is a leading provider of high-quality healthcare services in China. The company strives to offer its customers a comprehensive range of services focused on the needs of patients. Furthermore, the group also has a subsidiary, Fosun Industrial Co Ltd, specializing in the manufacturing and marketing of chemicals and plastic products. This perfectly complements the company's portfolio and enables it to serve more customers. The company also offers various health products, including dietary supplements, medical aids, and wellness products. These products are sold in the company's own pharmacies as well as retail pharmacies nationwide. Shanghai Fosun Pharma also operates in overseas markets, with branches in various countries around the world. The company aims to bring product quality and innovation to the global market in order to make them accessible to an even larger part of society. In summary, the business model of Shanghai Fosun Pharmaceutical Group Co Ltd is based on innovation and differentiation through research and development, manufacturing, and distribution of drugs, medical services, and products. The company has a strong presence in the healthcare market and delivers world-leading products and services.

Kolika je Shanghai Fosun Pharmaceutical Group Co dividenda?

Shanghai Fosun Pharmaceutical Group Co isplaćuje dividendu od 0,56 CNY raspoređenu preko isplata u toku godine.

Koliko često Shanghai Fosun Pharmaceutical Group Co isplaćuje dividendu?

Dividenda za Shanghai Fosun Pharmaceutical Group Co trenutno ne može biti izračunata ili kompanija ne isplaćuje dividendu.

Šta je Shanghai Fosun Pharmaceutical Group Co ISIN?

ISIN od Shanghai Fosun Pharmaceutical Group Co je CNE000000X38.

Koji je Shanghai Fosun Pharmaceutical Group Co berzanski simbol?

Oznaka za praćenje akcija kompanije Shanghai Fosun Pharmaceutical Group Co je 600196.SS.

Kolika je dividenda koju isplaćuje Shanghai Fosun Pharmaceutical Group Co?

U poslednjih 12 meseci, Shanghai Fosun Pharmaceutical Group Co je isplatio dividendu u iznosu od 0,42 CNY . To odgovara dividendnom prinosu od oko 1,82 %. Za narednih 12 meseci, Shanghai Fosun Pharmaceutical Group Co će verovatno isplatiti dividendu od 0,44 CNY.

Kolika je dividendna prinosa za Shanghai Fosun Pharmaceutical Group Co?

Dividendski prinos od Shanghai Fosun Pharmaceutical Group Co trenutno iznosi 1,82 %.

Kada Shanghai Fosun Pharmaceutical Group Co isplaćuje dividendu?

Shanghai Fosun Pharmaceutical Group Co isplaćuje dividende na kvartalnom nivou. One se isplaćuju u mesecima август, август, јул, септембар.

Koliko je sigurna dividenda od Shanghai Fosun Pharmaceutical Group Co?

Shanghai Fosun Pharmaceutical Group Co je isplaćivao dividendu svake godine u poslednjih 23 godina.

Kolika je dividenda kompanije Shanghai Fosun Pharmaceutical Group Co?

Za narednih 12 meseci očekuju se dividende u iznosu od 0,44 CNY. To odgovara dividendnom prinosu od 1,92 %.

U kom sektoru se nalazi Shanghai Fosun Pharmaceutical Group Co?

Shanghai Fosun Pharmaceutical Group Co se svrstava u sektor 'Zdravlje'.

Wann musste ich die Aktien von Shanghai Fosun Pharmaceutical Group Co kaufen, um die vorherige Dividende zu erhalten?

Da biste primili poslednju dividendu od Shanghai Fosun Pharmaceutical Group Co od 9. 8. 2023. u iznosu od 0,42 CNY, morali ste da imate akciju u depou pre Ex-dana 9. 8. 2023..

Kada je Shanghai Fosun Pharmaceutical Group Co poslednji put isplatio dividendu?

Isplata poslednje dividende izvršena je 9. 8. 2023..

Kolika je bila dividenda od Shanghai Fosun Pharmaceutical Group Co u godini 2023?

U godini 2023 kompanija Shanghai Fosun Pharmaceutical Group Co je isplatila 0,56 CNY kao dividende.

U kojoj valuti Shanghai Fosun Pharmaceutical Group Co isplaćuje dividendu?

Dividende od Shanghai Fosun Pharmaceutical Group Co se isplaćuju u CNY.

1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3,95
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1,80	2,34
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	50,00	-188,00
66,00	-37,00	-52,00	-107,00	-150,00	-199,00	-308,00	-347,00	-341,00	-497,00	-470,00	-570,00	-535,00	-1.220,00	-2.103,00	-3.171,00	-3.721,00	-4.956,00	-5.976,00	-7.424,00	-11.359,00	-13.569,00	-12.871,00	-15.073,00	-18.041,00
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-2.996,00	-572,00
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
-14,00	-24,00	-14,00	-40,00	-65,00	-129,00	-239,00	-205,00	-185,00	-184,00	-209,00	-336,00	-363,00	-616,00	-755,00	-963,00	-1.171,00	-1.395,00	-1.560,00	-1.959,00	-2.410,00	-2.275,00	-2.196,00	-1.836,00	-1.609,00
0,07	0,04	0,14	0,07	0,10	0,15	0,21	0,19	0,18	0,13	0,23	0,26	0,20	0,32	0,67	1,01	1,20	1,62	2,11	2,58	2,95	3,22	2,58	3,95	4,22
-52,00	-78,00	-126,00	-141,00	-139,00	-264,00	-205,00	-222,00	-266,00	-209,00	-210,00	-348,00	-339,00	-796,00	-1.160,00	-1.040,00	-1.119,00	-1.235,00	-1.922,00	-2.170,00	-3.174,00	-3.962,00	-4.437,00	-4.972,00	-5.888,00
-99,00	-238,00	-443,00	-487,00	-150,00	162,00	-779,00	-437,00	-336,00	-53,00	56,00	-397,00	-264,00	-1.766,00	-978,00	-1.803,00	-2.478,00	-1.869,00	-2.447,00	-10.504,00	-5.244,00	-172,00	-4.706,00	-3.856,00	-4.064,00
-0,05	-0,16	-0,32	-0,35	-0,01	0,43	-0,57	-0,22	-0,07	0,16	0,27	-0,05	0,07	-0,97	0,18	-0,76	-1,36	-0,63	-0,53	-8,33	-2,07	3,79	-0,27	1,12	1,82
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
-0,02	0,01	0,08	0,50	0,09	-0,29	0,16	0,35	0,80	0,38	-0,09	0,68	1,72	1,52	-0,46	-0,03	3,09	2,00	0,57	8,93	2,39	-2,44	2,25	1,81	3,75
372,00	77,00	435,00	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0,34	0,04	0,47	0,45	0,02	0,59	0,01	0,15	0,37	0,14	-0,35	0,40	1,82	0,91	2,07	-0,93	1,86	0,55	1,45	9,91	3,14	-1,94	1,47	-0,83	4,43
-0,00	-0,03	-0,04	0,04	0,02	0,98	0,01	0,03	-0,00	0,02	0,02	0,02	0,48	-0,06	3,23	0,15	-0,10	-0,34	2,07	2,41	4,30	2,37	1,05	-0,73	3,06
-7,00	-10,00	-4,00	-84,00	-91,00	-105,00	-149,00	-228,00	-428,00	-258,00	-277,00	-302,00	-378,00	-543,00	-707,00	-1.058,00	-1.126,00	-1.109,00	-1.193,00	-1.433,00	-3.551,00	-1.864,00	-1.834,00	-1.913,00	-2.374,00
0,32	-0,06	0,37	0,25	0,29	1,38	0,19	0,64	0,93	1,03	0,85	1,43	2,86	1,61	5,27	3,39	6,69	8,31	10,84	13,78	17,55	20,18	16,69	19,98	28,58
14,40	-39,80	11,80	-73,30	-37,00	-114,00	0,10	-34,30	-81,70	-78,20	22,40	-86,20	-135,80	-480,20	-495,10	-28,50	80,80	385,50	188,00	409,60	-224,80	-739,70	-1.857,30	-1.023,84	-1.671,27
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Direktne emisije	289.044
Indirektne emisije iz kupljene energije	659.631
Indirektne emisije unutar lanca vrednosti	794
CO₂ emisije	948.675
Strategija redukcije CO₂	✅
Ugalj energija	❌
Atomska energija	❌
Eksperimenti na životinjama	✅
Pelz & Leder	—
Pesticidi	—
Palmino ulje	—
Tabak	❌
Gentechnika	❌
Koncept klime	—
Održivo šumarstvo	—
Pravila o reciklaži	✅
Ekološka ambalaža	✅
Opasne materije	✅
Potrošnja i efikasnost goriva	✅
Potrošnja i efikasnost vode	✅

Udeo žena zaposlenih	48,48
Udeo žena u menadžmentu	—
Udeo azijskih zaposlenih	—
Udeo azijskog menadžmenta	—
Udeo hispansko/latinskih zaposlenih	—
Udeo hispano/latino menadžmenta	—
Udeo crnačkih zaposlenih	—
Udeo crnačkog menadžmenta	—
Udeo belih zaposlenih	—
Udeo belačkog menadžmenta	—
Sadržaji za odrasle	❌
Alkohol	❌
Odbrana	—
oružje	❌
Kockanje	❌
Ugovori o vojsci	❌
Koncept ljudskih prava	✅
Koncept zaštite podataka	—
Zaštita na radu i zdravlje	✅
Katolički	✅

Izveštaj o održivosti	✅
Angažovanje zainteresovanih strana	✅
Politika povlačenja	❌
Antimonopolsko pravo	❌

Shanghai Fosun Pharmaceutical Group Co Тикер	Shanghai Fosun Pharmaceutical Group Co FIGI
600196:CH	BBG000C4SR52
600196:CG	BBG000C4SRF1
600196:C1	BBG00709HHX2

1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024e	2025e	2026e
0,19	0,34	0,49	0,57	0,73	1,03	2,16	2,43	2,99	4,08	3,69	3,77	3,87	4,56	6,49	7,34	10,00	12,03	12,61	14,63	18,53	24,92	28,59	30,31	39,01	43,95	41,40	45,24	49,15	53,25
-	78,95	43,24	16,43	28,40	41,76	108,82	12,53	23,26	36,57	-9,53	2,17	2,62	17,64	42,39	13,18	36,17	20,31	4,85	16,02	26,69	34,44	14,72	6,02	28,70	12,68	-5,81	9,29	8,63	8,35
36,84	37,06	42,71	43,56	37,23	34,40	26,91	31,22	29,98	21,34	26,59	27,67	32,02	33,90	37,63	43,62	44,22	43,87	49,78	53,81	58,84	58,34	59,57	55,47	47,97	47,09	47,54	-	-	-
0,07	0,13	0,21	0,25	0,27	0,36	0,58	0,76	0,90	0,87	0,98	1,04	1,24	1,54	2,44	3,20	4,42	5,28	6,28	7,87	10,91	14,54	17,03	16,81	18,71	20,70	19,68	0	0	0
0,05	0,07	0,11	0,10	0,08	0,07	0,06	0,15	0,14	0,09	0,16	0,12	0,16	0,16	0,32	0,55	1,03	1,11	1,36	1,64	2,24	2,29	2,49	2,64	2,55	3,50	1,29	2,41	2,75	2,71
27,37	20,88	21,77	17,11	10,44	6,88	2,92	6,31	4,78	2,25	4,44	3,13	4,05	3,58	5,00	7,53	10,30	9,19	10,81	11,23	12,06	9,17	8,71	8,72	6,54	7,97	3,10	5,33	5,59	5,09
0,04	0,06	0,09	0,10	0,14	0,15	0,26	0,22	0,16	0,26	0,63	0,69	2,50	0,86	1,17	1,56	1,58	2,11	2,46	2,81	3,12	2,71	3,32	3,66	4,74	3,73	2,39	2,78	3,24	3,67
-	55,00	50,00	10,75	38,83	2,80	76,19	-16,99	-26,05	62,26	142,64	10,38	261,51	-65,41	34,95	34,13	1,21	33,48	16,42	14,07	11,33	-13,32	22,67	10,26	29,27	-21,22	-36,03	16,55	16,33	13,51
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
0,55	1,42	1,42	1,49	1,49	1,49	1,49	1,61	1,62	1,86	1,86	1,86	1,86	1,89	1,90	2,24	2,24	2,30	2,32	2,33	2,46	2,52	2,56	2,56	2,56	2,61	2,67	0	0	0
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Napravi najbolje investicije svog života. fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Cena

Cena

Тикер600196.SS

ISINCNE000000X38

Shanghai Fosun Pharmaceutical Group Co Akcija Promet, EBIT, Dobit CNE000000X38 ·

Promet, Profit & EBIT

Razumevanje prometa, EBIT-a i prihoda

Godišnja analiza i poređenja

Koristite očekivanja za investiranje

Uvid u investicije

Shanghai Fosun Pharmaceutical Group Co Prihod, dobit i EBIT istorija

Shanghai Fosun Pharmaceutical Group Co Akcija Kennzahlen

GuV

Prihod i rast

Bruto marža

EBIT i EBIT marža

Prihod i rast

Izdate akcije

Interpretacija godišnje usporedbe

Očekivanja i prognoze

Bilans

Razumevanje bilansa

Sredstva

Obaveze

Kapital

Analiza iz godine u godinu

Interpretacija podataka

Shanghai Fosun Pharmaceutical Group Co Акција Маргине CNE000000X38 ·

Margine

Razumevanje bruto marže

Analiza marže EBIT

Uvidi u maržu obrta

Tumačenje očekivanja

Analiza poređenja

Shanghai Fosun Pharmaceutical Group Co Istorija margine

Shanghai Fosun Pharmaceutical Group Co акција промет, EBIT, добит по акцији CNE000000X38 ·

Promet, EBIT i Zarada po deonici

Promet po deonici

EBIT po deonici

Prihod po deonici

Očekivane vrednosti

Shanghai Fosun Pharmaceutical Group Co Promet, dobit i EBIT po akciji - istorija

Shanghai Fosun Pharmaceutical Group Co Akcija i analiza akcija

Shanghai Fosun Pharmaceutical Group Co Ocena na osnovu istorijskog KGV, EBIT i KUV

Shanghai Fosun Pharmaceutical Group Co Broj akcija CNE000000X38 ·

Promet, EBIT i Zarada po deonici

Promet po deonici

EBIT po deonici

Prihod po deonici

Očekivane vrednosti

Shanghai Fosun Pharmaceutical Group Co Deonice podataka

Shanghai Fosun Pharmaceutical Group Co Akcija Dividenda CNE000000X38 ·

Dividenda

Pregled dividendi

Interpretacija i upotreba

Investiciona strategija

Shanghai Fosun Pharmaceutical Group Co Istorija dividendi

Shanghai Fosun Pharmaceutical Group Co акција стопа дистрибуције CNE000000X38 ·

Payout ratio

Šta je godišnji payout ratio?

Kako interpretirati podatke

Korišćenje podataka za investicije

Shanghai Fosun Pharmaceutical Group Co Istorija istorije isplate dividendi

Shanghai Fosun Pharmaceutical Group Co Procene zarade

Shanghai Fosun Pharmaceutical Group Co Iznenađenja u zaradi

Eulerpool ESG ocena za akciju Shanghai Fosun Pharmaceutical Group Co

Eulerpool World ESG Rating (EESG©)

95/ 100

🌱 Environment

👫 Social

🏛️ Governance

Životna sredina (Environment)

Društveno (Social)

Upravljanje preduzećem (Governance)

Shanghai Fosun Pharmaceutical Group Co Akcija Struktura vlasništva

Shanghai Fosun Pharmaceutical Group Co Upravni i Nadzorni odbor

Česta pitanja o Shanghai Fosun Pharmaceutical Group Co akciji

What values and corporate philosophy does Shanghai Fosun Pharmaceutical Group Co represent?

In which countries and regions is Shanghai Fosun Pharmaceutical Group Co primarily present?

Napravi najbolje investicije svog života.
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Тикер
600196.SS

ISIN
CNE000000X38